Wall Street Journal reported that the US Food and Drug Administration (FDA) wants some manufacturers to stop making prescription cold and allergy medicines containing carbinoxamine because the drug has not been approved by the government. There are at least 120 medications containing this compound and the only company that has gained FDA approval to sell this drug as a tablet or oral solution for allergic reactions is Mikart Inc.
There has been 21 deaths reported in children due to use of this product since 1983.
